Document is current
Any future updates will be listed below
-
Authors
Sakurai, Koki https://orcid.org/0000-0001-6952-7749
Morita, Makiko
Aomine, Yoshiatsu https://orcid.org/0009-0005-1569-8207
Matsumoto, Mitsunobu
Moriyama, Tetsuji
Kasahara, Emiko https://orcid.org/0009-0002-2952-0256
Sekiyama, Atsuo
Otani, Mayumi
Oshima, Rieko
Loveland, Kate L.
Yamada, Masami
Yoneda, Yoshihiro
Oka, Masahiro https://orcid.org/0000-0003-0123-3060
Hikida, Takatoshi https://orcid.org/0000-0002-8653-311X
Miyamoto, Yoichi https://orcid.org/0000-0003-4016-1119
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP20K06455)
MEXT | Japan Society for the Promotion of Science (JP22KK0111)
MEXT | Japan Society for the Promotion of Science (JP15K07068)
MEXT | Japan Society for the Promotion of Science (16H04789)
MEXT | Japan Society for the Promotion of Science (16H04789)
MEXT | Japan Society for the Promotion of Science (20H03444)
MEXT | Japan Society for the Promotion of Science (23K27373)
MEXT | Japan Society for the Promotion of Science (17H03679)
MEXT | Japan Society for the Promotion of Science (JP22H02944)
MEXT | Japan Society for the Promotion of Science (JP23K18163)
MEXT | Japan Science and Technology Agency (JPMJSP2138)
MEXT | Japan Science and Technology Agency (JPMJSP2138)
Japan Agency for Medical Research and Development (23ama121052)
Japan Agency for Medical Research and Development (JP23ama121054)
Japan Agency for Medical Research and Development (23ama121052)
Japan Agency for Medical Research and Development (JP23ama121054)
Japan Agency for Medical Research and Development (JP21wm0425010)
Japan Agency for Medical Research and Development (21gm1510006)
Salt Science Research Foundation (2229)
- License Information
-
More Information
Article History
Received: 25 June 2024
Revised: 24 September 2024
Accepted: 26 September 2024
First Online: 8 October 2024
Competing interests
: MMatsumoto is a employee of Miltenyi Biotec K.K. (Tokyo, Japan). All other authors declare that no conflict of interest exists.
: All animal experiments complied with institutional guidelines by the Institutional Safety Committee on Recombinant DNA Experiments (Nos. 04219 and 04884) at Osaka University (No. 110083) and (No. DNA-420) at NIBIOHN, Animal Experimental Committee of the Institute for Protein Research at Osaka University (Nos. 29-02-1 and R04-01-1), the Animal Care and Use Committee of Kyoto University (No. MedKyo17071), and animal research committees of NIBIOHN (No. DS26-34). All animal experiments were conducted in compliance with the ARRIVE guidelines. No human subjects and materials were involved in this study.
